Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

MDGL Madrigal Pharmaceuticals Inc

336,40

7,16 (2,17%)

Última atualização: 11:57:20

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/10/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ William John Sibold

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Click aqui para mais gráficos Madrigal Pharmaceuticals.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024

Click aqui para mais gráficos Madrigal Pharmaceuticals.

Notícias Madrigal Pharmaceuticals Inc

Form 144 - Report of proposed sale of securities
Quinta, 21 de Novembro de 2024 (18 horas atrás) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Quinta, 14 de Novembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Sexta, 8 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Quinta, 7 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
Quarta, 6 de Novembro de 2024 (2 semanas atrás) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Terça, 5 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sexta, 1 de Novembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Quinta, 31 de Outubro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quinta, 31 de Outubro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Quinta, 31 de Outubro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
Quinta, 31 de Outubro de 2024 (3 semanas atrás) • GlobeNewswire Inc.

Mais Notícias de Madrigal Pharmaceuticals Inc

Índice Bovespa

Grupo Casas Bahia ON

$Logo da Infracommerce Caxaas ON (IFCM3).$

Infracommerce Caxaas ON

Ambipar Participacoes e ... ON

Agrogalaxy Participacoes ON

HOTEIS OTHON PN

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições